Pace Corporate

Company broadens service offerings and strengthens network by purchasing Catalent’s Center-of-Excellence for Small Molecule Analytical Services facility in North Carolina Minneapolis, MN – September [26], 2024 – Pace® Life Sciences, LLC, a contract development, and manufacturing organization (CDMO) and a Division of Pace®, a Science and Technology Company, announced today that it has acquired from […]

Alternative delivery methods for biologics continues to be explored that offer less invasive, less painful administration. Despite their track record of demonstrating significant therapeutic efficacy, biologics still face daunting challenges in their drug delivery. Biologics such as monoclonal antibodies (mAbs) and some vaccines are largely administered via injection or by infusion. These methods can often

Proven track record of consistent high quality confirmed at Pace® Life Sciences headquarters MINNEAPOLIS, MN., July 25, 2024 (NEWSWIRE.COM): Pace® Life Sciences, a full-service FDA-registered GMP Analytical Testing laboratory and contract development and manufacturing organization (CDMO) and a Division of Pace®, a Science and Technology Company, announced today a successful inspection from The Food &

Bornilla brings over 25 years of commercial pharmaceutical experience to Pace® MINNEAPOLIS (July 23, 2024) – Pace® Life Sciences, a full-service contract development and manufacturing organization (CDMO) and a Division of Pace®, a Science and Technology Company, announced today that Dean Bornilla has been named Head of Commercial reporting to Dawn Von Rohr, President, Pace® Life